PD-014Survival following curative indented treatment of brain metastases from colorectal cancer: A Danish population-based cohort study

Introduction: Brain metastases (BM) are an uncommon presentation of metastatic colorectal cancer (mCRC) with reported incidence of about 2-4%. Previously, the focus has been on a palliative treatment course with whole brain radiation, corticosteroids and supportive care, resulting in an expected survival of a few months. Today, there is an increased awareness towards a localized curative intended treatment approach with either surgical resection, stereotactic body radiotherapy (SBRT) or both. We examined the survival for patients treated with a localized modality for BM from CRC in a nationwide population-based study.